z-logo
open-access-imgOpen Access
The Role of PPARs in the Endothelium: Implications for Cancer Therapy
Author(s) -
David BishopBailey,
Karen E. Swales
Publication year - 2008
Publication title -
ppar research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 49
eISSN - 1687-4765
pISSN - 1687-4757
DOI - 10.1155/2008/904251
Subject(s) - angiogenesis , metastasis , inflammation , endothelium , medicine , cancer research , coagulation , platelet , endothelial stem cell , receptor , cancer , immunology , microbiology and biotechnology , biology , in vitro , biochemistry
The growth and metastasis of cancers intimately involve the vasculature and in particular the endothelial cell layer. Tumours require new blood vessel formation via angiogenesis to support growth. In addition, inflammation, coagulation, and platelet activation are common signals in the growth and metastasis of tumour cells. The endothelium plays a central role in the homeostatic control of inflammatory cell recruitment, regulating platelet activation and coagulation pathways. PPAR α , - β / δ , and - γ are all expressed in endothelial cells. This review will discuss the roles of PPARs in endothelial cells in relation to angiogenesis, inflammation, coagulation, and platelet control pathways. In particular, we will discuss the recent evidence that supports the hypothesis that PPAR α and PPAR γ are antiangiogenic receptors, while PPAR β / δ is proangiogenic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom